Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 14:5:e56405.
doi: 10.2196/56405.

Incidence of Postoperative Diabetes Mellitus After Roux-en-Y Reconstruction for Gastric Cancer: Retrospective Single-Center Cohort Study

Affiliations

Incidence of Postoperative Diabetes Mellitus After Roux-en-Y Reconstruction for Gastric Cancer: Retrospective Single-Center Cohort Study

Tatsuki Onishi. JMIRx Med. .

Abstract

Background: Sleeve gastrectomy is an effective surgical option for morbid obesity, and it improves glucose homeostasis. In patients with gastric cancer and type 2 diabetes mellitus (DM), gastrectomy, including total gastrectomy, is beneficial for glycemic control.

Objective: This study aims to clarify the effects of gastrectomy and different reconstructive techniques on the incidence of postoperative DM in patients with gastric cancer.

Methods: This retrospective, single-center, cohort study included 715 patients without DM who underwent total gastrectomy at the Tokyo Metropolitan Bokutoh Hospital between August 2005 and March 2019. Patients underwent reconstruction by Roux-en-Y (RY) gastric bypass or other surgical techniques (OT), with DM onset determined by hemoglobin A1c levels or medical records. Analyses included 2-sample, 2-tailed t tests; χ2 tests; and the Kaplan-Meier method with log-rank tests to compare the onset curves between the RY and OT groups, along with additional curves stratified by sex. A Swimmer plot for censoring and new-onset DM was implemented.

Results: Stratified data analysis compared the RY and OT reconstruction methods. The hazard ratio was 1.52 (95% CI 1.06-2.18; P=.02), which indicated a statistically significant difference in the incidence of new-onset diabetes between the RY and OT groups in patients with gastric cancer. The hazard ratio after propensity score matching was 1.42 (95% CI 1.09-1.86; P=.009).

Conclusions: This first-of-its-kind study provides insight into how different methods of gastric reconstruction affect postoperative diabetes. The results suggest significant differences in new-onset DM after surgery based on the reconstruction method. This research highlights the need for careful surgical planning to consider potential postoperative DM, particularly in patients with a family history of DM. Future studies should investigate the role of gut microbiota and other reconstructive techniques, such as laparoscopic jejunal interposition, in developing postoperative DM.

Keywords: diabetes mellitus; gastrectomy; gastric cancer surgery; glucose metabolism; postoperative diabetes onset; surgery outcomes.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1.
Figure 1.. Kaplan-Meier curve of new-onset DM in the RY and OT groups. DM: diabetes mellitus; OT: other surgical techniques; RY: Roux-en-Y.
Figure 2.
Figure 2.. Swimmer plot of new-onset DM and death. DM: diabetes mellitus; OT: other surgical techniques; RY: Roux-en-Y.
Figure 3.
Figure 3.. Density histogram (A) before and (B) after propensity score matching, and (C) Kaplan-Meier curve of new-onset DM after propensity score matching. DM: diabetes mellitus; OT: other surgical techniques; RY: Roux-en-Y.
Figure 4.
Figure 4.. Kaplan-Meier curve of new-onset DM stratified by sex: (A) male and (B) female. DM: diabetes mellitus; OT: other surgical techniques; RY: Roux-en-Y.

Update of

  • doi: 10.1101/2024.01.13.24301276

References

    1. Gumbs AA, Gagner M, Dakin G, Pomp A. Sleeve gastrectomy for morbid obesity. Obes Surg. 2007 Jul;17(7):962–969. doi: 10.1007/s11695-007-9151-x. doi. Medline. - DOI - PubMed
    1. Huang R, Ding X, Fu H, Cai Q. Potential mechanisms of sleeve gastrectomy for reducing weight and improving metabolism in patients with obesity. Surg Obes Relat Dis. 2019 Oct;15(10):1861–1871. doi: 10.1016/j.soard.2019.06.022. doi. Medline. - DOI - PubMed
    1. Butte JM, Devaud N, Jarufe NP, et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation. Obes Surg. 2007 Nov;17(11):1517–1519. doi: 10.1007/s11695-008-9432-z. doi. Medline. - DOI - PubMed
    1. Rawlins L, Rawlins MP, Brown CC, Schumacher DL. Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis. 2013;9(1):21–25. doi: 10.1016/j.soard.2012.08.014. doi. Medline. - DOI - PubMed
    1. Armstrong J, O’Malley SP. Outcomes of sleeve gastrectomy for morbid obesity: a safe and effective procedure? Int J Surg. 2010;8(1):69–71. doi: 10.1016/j.ijsu.2009.11.004. doi. Medline. - DOI - PubMed

LinkOut - more resources